MBody AI MBAI
NASDAQ MBAI
$3.54 -0.24 (-6.35%)
At close: Sep 30, 2026 · 4:00 PM EDT

MBody AI (MBAI) Current Deferred Revenue (2021 - 2022)

Updated

MBody AI's Current Deferred Revenue came in at $1.17 million for the quarter ended Dec 31, 2022, down 39.0% from $1.91 million a year earlier.

Analysis

MBody AI (MBAI) Current Deferred Revenue (2021 - 2022) Analysis & Trends

  • Going back by year, Current Deferred Revenue was $1.91 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 MBody AI 3.55 Mn 3.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.17 Mn
Dec 31, 2021 1.91 Mn
API Access

MBody AI Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MBAI&period=max&api_key=YOUR_API_KEY